What's Next for Geron and Imetelstat?

There's a lot of promise and plenty of potential for failure built into imetelstat at this point, and the opportunities and threats afforded by this potential therapy for myelofibrosis, polycythemia vera, and multiple myeloma certainly merit a closer examination.

http://ift.tt/PPKdU8